MYALGIC ENCEPHALOMYELITIS
Clinical trials for MYALGIC ENCEPHALOMYELITIS explained in plain language.
Never miss a new study
Get alerted when new MYALGIC ENCEPHALOMYELITIS trials appear
Sign up with your email to follow new studies for MYALGIC ENCEPHALOMYELITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a clot-busting enzyme ease long COVID and chronic fatigue?
Symptom relief Recruiting nowThis early-stage study tests lumbrokinase, an enzyme that breaks down blood clots, in 120 adults with Long COVID, post-treatment Lyme disease syndrome, or ME/CFS. Participants rate their overall health before and after treatment to see if the enzyme improves quality of life. The …
Matched conditions: MYALGIC ENCEPHALOMYELITIS
Phase: PHASE1, PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated May 26, 2026 05:27 UTC
-
Could a 3-Day course ease chronic fatigue? new trial seeks answers
Symptom relief Recruiting nowThis study tests whether a 3-day course can improve physical function and reduce fatigue in adults with Chronic Fatigue Syndrome (CFS/ME). Researchers will enroll 100 people who have a CFS/ME diagnosis and are at least 50% out of school or work. The goal is to find an effective t…
Matched conditions: MYALGIC ENCEPHALOMYELITIS
Phase: NA • Sponsor: Norwegian University of Science and Technology • Aim: Symptom relief
Last updated May 26, 2026 05:26 UTC
-
Can an antioxidant boost brain health in chronic fatigue?
Knowledge-focused Recruiting nowThis study is for adults aged 21-60 with ME/CFS (chronic fatigue syndrome). It tests different doses of N-Acetylcysteine (NAC), an antioxidant, to see how it affects brain glutathione levels and markers of oxidative stress. The goal is to understand how NAC works in the brain, no…
Matched conditions: MYALGIC ENCEPHALOMYELITIS
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated May 26, 2026 04:35 UTC